Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 120
Titolo Tipologia Data di pubblicazione Autori File
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 01 - Articolo su rivista 2022 Fazio, GraziaQuadri, ManuelSaitta, ClaudiaPalmi, ChiaraBardini, MichelaGrioni, AndreaSavino, Angela MariaConter, ValentinoRizzari, CarmeloValsecchi, Maria GraziaBiondi, AndreaCazzaniga, Giovanni +
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war 01 - Articolo su rivista 2022 Rizzari C. +
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 01 - Articolo su rivista 2022 Biondi, AndreaValsecchi, Maria GraziaRizzari, CarmeloConter, ValentinoCazzaniga, Giovanni +
The impact of the EU General Data Protection Regulation on childhood cancer research in Europe 01 - Articolo su rivista 2022 Rizzari C. +
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO 01 - Articolo su rivista 2022 Molinaro A.Zanta D.Rizzari C.Biondi A. +
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 01 - Articolo su rivista 2022 Rizzari C.Conter V. +
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study 01 - Articolo su rivista 2022 Rizzari C. +
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child 01 - Articolo su rivista 2022 Faraguna M. C.Musto F.Crescitelli V.Fedeli T.Kullmann G.Cattoni A.Dell'acqua F.Rizzari C. +
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach 01 - Articolo su rivista 2022 Rizzari C. +
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial 01 - Articolo su rivista 2022 Rizzari C. +
Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers 01 - Articolo su rivista 2022 Rizzari C. +
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study 01 - Articolo su rivista 2022 Rizzari C. +
Biological therapies in monogenic autoinflammatory diseases: Long-term efficacy and safety 02 - Intervento a convegno 2021 Pelagatti, MACattoni, ARizzari, C
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 01 - Articolo su rivista 2021 Saettini F.Castelli I.Fazio G.Quadri M.Cazzaniga G.Balduzzi A. C.Biondi A.Rizzari C.Bonanomi S. +
ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment 01 - Articolo su rivista 2021 Dander, EricaBardelli, DonatellaFallati, AlessandraRizzari, CarmeloBiondi, Andrea +
Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study 01 - Articolo su rivista 2021 Colombini A.Pelagatti M. A.Biondi A.Conter V.Rizzari C. +
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 01 - Articolo su rivista 2021 Fazio G.Bardini M.Grioni A.Quadri M.Palmi C.Conter V.Rizzari C.Valsecchi M. G.Biondi A.Cazzaniga G. +
A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety 01 - Articolo su rivista 2021 Rizzari C. +
Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process 01 - Articolo su rivista 2021 Rizzari C. +
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival among Children with High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial 01 - Articolo su rivista 2021 Rizzari C. +
Mostrati risultati da 21 a 40 di 120
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile